PHARMACOKINETICS AND TOXICITY OF 2ND LINE ANTI-TB DRUGS IN HIV-INFECTED CHILDREN

Pascale Willem

The Coding Genome Of HIV-Associated Plasmablastic Lymphomas In South Africa

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Leona W Ayers

Mid-Region Aids and Cancer Specimen Resource Consortium

Hodgkin lymphoma Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Michael A Gelman

Antivirals for Hepatitis C Targeting Phosphoinositide Metabolism

Liver and intrahepatic bile ducts

Michael Wang

A Phase II, Multicenter, International Study of Lenalidomide and Rituximab in Relapsed/Refractory Mantle Cell Lymphoma, Diffuse Large B-Cell Non-Hodgkin Lymphoma, Transformed Large Cell Lymphoma, and Grade 3 Follicular Lymphoma

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Stephen G Emerson

Palliative care and end-of-life issues among cancer patients in Soweto, South Africa

Trachea, bronchus and lung Pancreas Oesophagus Liver and intrahepatic bile ducts Colorectum Breast

Ulf Klein

The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis

Non-Hodgkin lymphoma Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Manoj Menon

AMC PROTOCOL #075: A Sequential Phase I/Randomized Phase II Trial of Vorinostat and Risk-Adapted Chemotherapy with Rituximab in HIV-Related B-Cell Non-Hodgkin’s Lymphoma. A Trial of the AIDS Malignancy Consortium (AMC)

Hodgkin lymphoma

Hematology and hematologic malignancies

Elliott D Kieff

Epstein-Barr Virus Nuclear Protein in B Cell Growth Transformation

Non-Hodgkin lymphoma Hodgkin lymphoma

Christian Steidl

Prognostic markers and biology of relapsed Hodgkin lymphoma

Hodgkin lymphoma